Armata Pharmaceuticals (ARMP) Equity Ratio: 2013-2018
Historic Equity Ratio for Armata Pharmaceuticals (ARMP) over the last 5 years, with Sep 2018 value amounting to 0.83.
- Armata Pharmaceuticals' Equity Ratio rose 16.99% to 0.83 in Q3 2018 from the same period last year, while for Sep 2018 it was 0.83, marking a year-over-year increase of 16.99%. This contributed to the annual value of 0.69 for FY2017, which is 29.59% up from last year.
- Latest data reveals that Armata Pharmaceuticals reported Equity Ratio of 0.83 as of Q3 2018, which was down 16.01% from 0.99 recorded in Q2 2018.
- In the past 5 years, Armata Pharmaceuticals' Equity Ratio registered a high of 28.37 during Q1 2018, and its lowest value of -0.91 during Q1 2014.
- Its 3-year average for Equity Ratio is 3.18, with a median of 0.70 in 2016.
- Per our database at Business Quant, Armata Pharmaceuticals' Equity Ratio fell by 11.04% in 2017 and then spiked by 6,002.79% in 2018.
- Over the past 5 years, Armata Pharmaceuticals' Equity Ratio (Quarterly) stood at 0.12 in 2014, then surged by 236.13% to 0.40 in 2015, then skyrocketed by 32.67% to 0.54 in 2016, then increased by 29.59% to 0.69 in 2017, then increased by 16.99% to 0.83 in 2018.
- Its Equity Ratio was 0.83 in Q3 2018, compared to 0.99 in Q2 2018 and 28.37 in Q1 2018.